PS
Patient Square Capital LP
MENLO PARK CA · SEC CIK 0001819257
$645.52M2026Q2 reported value
23Positions
80.1%Top 10 weight · largest 44.0%
6 / 12New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
RVMD New+$51.69M
UTHR New+$20.11M
BNTX New+$12.51M
ABVX Added+$11.36M
CCCC New+$7.51M
2026Q2 top sells estimated at quarter-end value
INSM Sold out-$25.75M
LEGN Sold out-$17.91M
NKTR Sold out-$15.11M
ARGX Reduced-$12.73M
CELC Sold out-$10.84M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | $283.86M | 43.97% | 8,020,928 | -145,119 | -1.8% | -$5.14M | Reduced |
| RVMD | REVOLUTION MEDICINES INC | $51.69M | 8.01% | 276,000 | 276,000 | — | $51.69M | New |
| MIRM | MIRUM PHARMACEUTICALS INC | $30.50M | 4.72% | 260,500 | 30,500 | 13.3% | $3.57M | Added |
| ABVX | ABIVAX SA | $27.52M | 4.26% | 206,500 | 85,255 | 70.3% | $11.36M | Added |
| ONC | BEONE MEDICINES LTD | $25.65M | 3.97% | 90,020 | 9,478 | 11.8% | $2.70M | Added |
| PHVS | PHARVARIS N V | $23.21M | 3.60% | 671,209 | 178,209 | 36.1% | $6.16M | Added |
| ARGX | ARGENX SE | $21.34M | 3.31% | 23,000 | -13,718 | -37.4% | -$12.73M | Reduced |
| UTHR | UNITED THERAPEUTICS CORP DEL | $20.11M | 3.12% | 37,120 | 37,120 | — | $20.11M | New |
| BLTE | BELITE BIO INC | $16.94M | 2.62% | 110,000 | -6,684 | -5.7% | -$1.03M | Reduced |
| COGT | COGENT BIOSCIENCES INC | $16.45M | 2.55% | 425,000 | -171,000 | -28.7% | -$6.62M | Reduced |
| DBVT | DBV TECHNOLOGIES S A | $14.92M | 2.31% | 909,474 | 215,940 | 31.1% | $3.54M | Added |
| XENE | XENON PHARMACEUTICALS INC | $13.28M | 2.06% | 220,000 | -7,000 | -3.1% | -$422,520 | Reduced |
| BNTX | BIONTECH SE | $12.51M | 1.94% | 134,429 | 134,429 | — | $12.51M | New |
| RCUS | ARCUS BIOSCIENCES INC | $10.97M | 1.70% | 355,800 | 160,800 | 82.5% | $4.96M | Added |
| ELVN | ENLIVEN THERAPEUTICS INC | $10.78M | 1.67% | 212,500 | 12,500 | 6.2% | $634,375 | Added |
| DNTH | DIANTHUS THERAPEUTICS INC | $10.53M | 1.63% | 108,000 | 14,118 | 15.0% | $1.38M | Added |
| ALLO | ALLOGENE THERAPEUTICS INC | $10.50M | 1.63% | 5,050,000 | 1,600,000 | 46.4% | $3.33M | Added |
| EYPT | EYEPOINT INC | $10.30M | 1.59% | 720,000 | -75,000 | -9.4% | -$1.07M | Reduced |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $9.70M | 1.50% | 370,000 | -30,645 | -7.6% | -$803,512 | Reduced |
| CCCC | C4 THERAPEUTICS INC | $7.51M | 1.16% | 1,608,815 | 1,608,815 | — | $7.51M | New |
| IVA | INVENTIVA SA | $7.44M | 1.15% | 1,967,171 | 1,967,171 | — | $7.44M | New |
| KYMR | KYMERA THERAPEUTICS INC | $5.45M | 0.84% | 47,500 | -52,500 | -52.5% | -$6.02M | Reduced |
| FTH | FAETH THERAPEUTICS INC | $4.38M | 0.68% | 175,050 | 175,050 | — | $4.38M | New |
| INSM | INSMED INC | $0 | 0.00% | 0 | -157,500 | -100.0% | -$25.75M | Sold out |
| LEGN | LEGEND BIOTECH CORP | $0 | 0.00% | 0 | -990,000 | -100.0% | -$17.91M | Sold out |
| NKTR | NEKTAR THERAPEUTICS | $0 | 0.00% | 0 | -210,000 | -100.0% | -$15.11M | Sold out |
| CELC | CELCUITY INC | $0 | 0.00% | 0 | -95,000 | -100.0% | -$10.84M | Sold out |
| MRK | MERCK & CO INC | $0 | 0.00% | 0 | -80,000 | -100.0% | -$9.62M | Sold out |
| CATX | PERSPECTIVE THERAPEUTICS INC | $0 | 0.00% | 0 | -1,625,000 | -100.0% | -$6.78M | Sold out |
| DFTX | DEFINIUM THERAPEUTICS INC | $0 | 0.00% | 0 | -331,000 | -100.0% | -$6.26M | Sold out |
| HROW | HARROW INC | $0 | 0.00% | 0 | -165,209 | -100.0% | -$5.83M | Sold out |
| TARA | PROTARA THERAPEUTICS INC | $0 | 0.00% | 0 | -1,030,846 | -100.0% | -$5.37M | Sold out |
| CTMX | CYTOMX THERAPEUTICS INC. | $0 | 0.00% | 0 | -1,085,790 | -100.0% | -$5.10M | Sold out |
| ASMB | ASSEMBLY BIOSCIENCES INC | $0 | 0.00% | 0 | -136,315 | -100.0% | -$3.78M | Sold out |
| SYRE | SPYRE THERAPEUTICS INC | $0 | 0.00% | 0 | -1,000 | -100.0% | -$50,440 | Sold out |